US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

25.890
+0.270+1.05%

Trading Sep 17 12:23 ET

2.13BMarket Cap-15981P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 14.243M	--
--	2024/Q3	-- / 14.660M	--
--	2024/Q2	11.772M / 13.047M	--
--	2024/Q1	7.410M / 14.664M	--
--	2023/Q4	316.192M / 33.673M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 14.243M--

--2024/Q3-- / 14.660M--

--2024/Q211.772M / 13.047M--

--2024/Q17.410M / 14.664M--

--2023/Q4316.192M / 33.673M--

Unlock Free Earnings Estimates

Open Account

Beam Therapeutics Earnings Reports

Beam Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 08:58 ET

Beam Therapeutics | 10-Q: Q1 2024 Earnings Report

May 7 07:24 ET

Beam Therapeutics | 10-K: FY2023 Annual Report

Feb 27 07:25 ET

Beam Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 8, 2023 07:30 ET

Analyst Rating

Updated: Sep 17, 2024

Buy

Buy
70.00%
Hold
30.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data